Atlas Trials

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors

Clinical trial NCT06013111 · RECRUITING

Trial details

NCT number
NCT06013111
Sponsor
China Medical University, China
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Carcinoma
Start date
2023-10-23
Primary completion
2026-09-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.